GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Other Financing

Kineta (STU:J75) Other Financing : €0.02 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kineta Other Financing?

Kineta's Other Financing for the three months ended in Mar. 2024 was €0.00 Mil.

Kineta's Other Financing for the trailing twelve months (TTM) ended in Mar. 2024 was €0.02 Mil.


Kineta Other Financing Historical Data

The historical data trend for Kineta's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta Other Financing Chart

Kineta Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Financing
0.01 0.02 0.07 0.03

Kineta Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 - 0.01 -

Kineta Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kineta Other Financing Related Terms

Thank you for viewing the detailed overview of Kineta's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Kineta (STU:J75) Business Description

Traded in Other Exchanges
Address
219 Terry Avenue North, Suite 300, Seattle, WA, USA, 98109
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Kineta (STU:J75) Headlines

No Headlines